312 related articles for article (PubMed ID: 35777588)
1. Resveratrol and resveratrol nano-delivery systems in the treatment of inflammatory bowel disease.
Gowd V; Kanika ; Jori C; Chaudhary AA; Rudayni HA; Rashid S; Khan R
J Nutr Biochem; 2022 Nov; 109():109101. PubMed ID: 35777588
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol and inflammatory bowel disease: the evidence so far.
Nunes S; Danesi F; Del Rio D; Silva P
Nutr Res Rev; 2018 Jun; 31(1):85-97. PubMed ID: 29191255
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol and inflammatory bowel disease.
Shi Y; Zhou J; Jiang B; Miao M
Ann N Y Acad Sci; 2017 Sep; 1403(1):38-47. PubMed ID: 28945937
[TBL] [Abstract][Full Text] [Related]
4. [Polyphenols in the treatment of inflammatory bowel diseases].
Chojnacka K; Laskowska J
Postepy Biochem; 2020 Sep; 66(3):256-262. PubMed ID: 33315320
[TBL] [Abstract][Full Text] [Related]
5. The application of natural product-delivering micro/nano systems in the treatment of inflammatory bowel disease.
Zhou Y; Feng X; Xu H; Guo J; Yang C; Kong L; Zhang Z
J Mater Chem B; 2023 Jan; 11(2):244-260. PubMed ID: 36512384
[TBL] [Abstract][Full Text] [Related]
6. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
[TBL] [Abstract][Full Text] [Related]
7. Polyphenol supplementation as a complementary medicinal approach to treating inflammatory bowel disease.
Biasi F; Astegiano M; Maina M; Leonarduzzi G; Poli G
Curr Med Chem; 2011; 18(31):4851-65. PubMed ID: 21919842
[TBL] [Abstract][Full Text] [Related]
8. An oral polyphenol host-guest nanoparticle for targeted therapy of inflammatory bowel disease.
Zhang C; Zeng F; Fan Z; He Z; Tai L; Peng Q; Zhang Y; Chao Z; Jiang W; Jia L; Han L
Acta Biomater; 2023 Oct; 169():422-433. PubMed ID: 37597682
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol Attenuates Inflammatory Bowel Disease in Mice by Regulating SUMO1.
Wang J; Zhang Z; Fang A; Wu K; Chen X; Wang G; Mao F
Biol Pharm Bull; 2020; 43(3):450-457. PubMed ID: 32115503
[TBL] [Abstract][Full Text] [Related]
10. Encapsulation of Polyphenolic Compounds Based on Hemicelluloses to Enhance Treatment of Inflammatory Bowel Diseases and Colorectal Cancer.
Caban M; Lewandowska U
Molecules; 2023 May; 28(10):. PubMed ID: 37241929
[TBL] [Abstract][Full Text] [Related]
11. Silk fibroin nanoparticles constitute a vector for controlled release of resveratrol in an experimental model of inflammatory bowel disease in rats.
Lozano-Pérez AA; Rodriguez-Nogales A; Ortiz-Cullera V; Algieri F; Garrido-Mesa J; Zorrilla P; Rodriguez-Cabezas ME; Garrido-Mesa N; Utrilla MP; De Matteis L; de la Fuente JM; Cenis JL; Gálvez J
Int J Nanomedicine; 2014; 9():4507-20. PubMed ID: 25285004
[TBL] [Abstract][Full Text] [Related]
12. A review on curcumin colon-targeted oral drug delivery systems for the treatment of inflammatory bowel disease.
Sardou HS; Vosough PR; Abbaspour M; Akhgari A; Sathyapalan T; Sahebkar A
Inflammopharmacology; 2023 Jun; 31(3):1095-1105. PubMed ID: 36757584
[TBL] [Abstract][Full Text] [Related]
13. Novel therapeutic targets for inflammatory bowel disease.
Argollo M; Fiorino G; Hindryckx P; Peyrin-Biroulet L; Danese S
J Autoimmun; 2017 Dec; 85():103-116. PubMed ID: 28711286
[TBL] [Abstract][Full Text] [Related]
14. Dietary Supplementation with Vitamin D, Fish Oil or Resveratrol Modulates the Gut Microbiome in Inflammatory Bowel Disease.
Wellington VNA; Sundaram VL; Singh S; Sundaram U
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008631
[TBL] [Abstract][Full Text] [Related]
15. Novel agents in the future: Therapy beyond anti-TNF agents in inflammatory bowel disease.
Peng JC; Shen J; Ran ZH
J Dig Dis; 2014 Nov; 15(11):585-90. PubMed ID: 25251263
[TBL] [Abstract][Full Text] [Related]
16. Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts.
Zhu X; Liu Q; Wang M; Liang M; Yang X; Xu X; Zou H; Qiu J
PLoS One; 2011; 6(11):e27081. PubMed ID: 22069489
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.
Yang C; Merlin D
Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol-loaded nanomedicines for cancer applications.
Annaji M; Poudel I; Boddu SHS; Arnold RD; Tiwari AK; Babu RJ
Cancer Rep (Hoboken); 2021 Jun; 4(3):e1353. PubMed ID: 33655717
[TBL] [Abstract][Full Text] [Related]
19. Effects of Wine Components in Inflammatory Bowel Diseases.
Vrdoljak J; Kumric M; Ticinovic Kurir T; Males I; Martinovic D; Vilovic M; Bozic J
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641434
[TBL] [Abstract][Full Text] [Related]
20. Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.
Piechota-Polanczyk A; Fichna J
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):605-20. PubMed ID: 24798211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
